Brief: Biocept Reports First Quarter 2023 Financial Results
May 10 (Reuters) - Biocept Inc BIOC.O :
* BIOCEPT REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
* BIOCEPT INC - NET REVENUES FOR Q1 OF 2023 WERE $0.7
MILLION,
COMPARED WITH $19.9 MILLION FOR Q1 OF 2022
* BIOCEPT INC - NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
FOR
Q1 OF 2023 WAS $7.1 MILLION, OR $0.41 PER SHARE
Source text for Eikon: ID:nBw7F3ySsa
Further company coverage: BIOC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biocept
See all newsBrief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Biocept slumps after filing for bankruptcy protection
Brief: Biocept CEO Antonino Morales Resigns
U.S. STOCKS ON THE MOVE-Albemarle, Novavax, WeWork